Brady Johnson - Jul 9, 2021 Form 3 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Vice President, Finance
Signature
/s/ Brady Johnson
Stock symbol
CDTX
Transactions as of
Jul 9, 2021
Transactions value $
$0
Form type
3
Date filed
7/19/2021, 02:55 PM
Next filing
Jul 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDTX Common Stock 26.4K Jul 9, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDTX Stock Option (right to buy) Jul 9, 2021 Common Stock 12.1K $2.45 Direct F1
holding CDTX Stock Option (right to buy) Jul 9, 2021 Common Stock 20K $2.45 Direct F2
holding CDTX Stock Option (right to buy) Jul 9, 2021 Common Stock 6.7K $1.98 Direct F3
holding CDTX Stock Option (right to buy) Jul 9, 2021 Common Stock 12.2K $2.55 Direct F4
holding CDTX Restricted Stock Unit Jul 9, 2021 Common Stock 524 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the shares subject to the option vested on December 18, 2020 and the remainder vests and becomes exercisable in a series of twenty-four (24) successive equal monthly installments thereafter until fully vested on December 18, 2022.
F2 Shares are fully vested
F3 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020.
F4 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.
F5 The shares shall vest upon the achievement of various clinical and corporate milestones.
F6 Restricted stock units convert into common stock on a one-for-one basis.